Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.
PMID: 32851910
2022
Journal of biomolecular structure & dynamics
Abstract: In our study, several mutations like R408I, L455Y, F486L, Q493N, Q498Y, N501T of RBD (319-591), and A930V, D936Y of HR1 (912-984) have been studied to examine its role on the spike glycoprotein native structure.
Introduction: The important RBD mutations like
Introduction: reported various mutations on spike glycoprotein and also highlighted the importance of R408I mutation responsible for lower ACE2 binding which revealed a higher risk of COVID-19 pandemic (Jia et al.,).
Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach.
PMID: 35370005
2022
Indian journal of medical microbiology
Discussion: A few mutants' viz.L455Y, Q493N, R408I, Q498Y, F486L, N501T within the RBD region (319-591), and D936Y& A930V within HR1 site (912-984) have also been studied by in silico analysis to investigate the basic structure of spike glycoprotein.
Discussion: Comparison of wild with mutant RBD protein, significant RMSD fluctuations were observed in all variants (B.1.617 0.25-0.5 nm, E484K nm 0.25-0.4 nm, F486L 0.2-0.3 nm, K417G 0.2-0.4 nm, L455Y 0.2-0.4 nm,
Computational investigation reveals that the mutant strains of SARS-CoV2 have differential structural and binding properties.
PMID: 34968787
2022
Computer methods and programs in biomedicine
Introduction: R408I (Arginine 408 to Isoleucine) mutant isolated from India.
Introduction: The rest of mutations V367F and R408I, mostly affected the overall topology and stability of RBD as these mutations present at the loop regions of N-terminal and turn that connect beta-sheet3 and 4, respectively.
Introduction: These mutations (V367F, R408I
Introduction: These mutations (V367F, R408I, G476S, V483A and N501Y) indirectly assist in the stable binding of RBD to the host ACE2 receptor.
E484K and N501Y SARS-CoV 2 spike mutants Increase ACE2 recognition but reduce affinity for neutralizing antibody.
PMID: 34915409
2022
International immunopharmacology
Table: R408I
Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study.
PMID: 34158771
2021
Ethiopian journal of health sciences
Table: R408I
Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.
PMID: 34103090
2021
European journal of medical research
Table: R408I
Bioinformatics Analysis Unveils Certain Mutations Implicated in Spike Structure Damage and Ligand-Binding Site of Severe Acute Respiratory Syndrome Coronavirus 2.
PMID: 34121839
2021
Bioinformatics and biology insights
Result: Eighty four whole spike protein sequences isolated from Africa are used, and the most common mutations are found to be Q667H (5 mutations), D614G (3 mutations), R408I (2 mutations), and others (1 mutations), which was found containing 8 different mutations (Table 1).
Table: R408I
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Result: Finally, there are several common contact residues in the C4 NAb epitope, suggesting that N370S, T376I, V382L, P384L, T385I, and R408I could disrupt C4 NAbs.
Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.
PMID: 34419160
2021
Infectious diseases of poverty
Table: R408I
A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels.